• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Closing Payer Gaps and Improving Fertility Care Access

Opinion
Video

Sean Tipton underscores the importance of payer adoption of new treatments and technology which can lead to better patient outcomes.

This is a video synopsis/summary of a Population Health Perspectives® involving Sean Tipton. In the video, Tipton stresses that all parties involved in reproductive care, from device manufacturers to payers and providers, share the goal of healthy patients able to build families. He highlights the importance of payers and providers maintaining open communication, aided by resources like the American Society for Reproductive Medicine (ASRM) that impartially evaluate new techniques’ readiness for widespread use based on aggregated data. Tipton advises that beyond covering infertility treatment, payers must actively work to understand evolving science and technology in partnership with providers and groups like ASRM. He suggests reducing patient demands could boost outcomes, enhance experiences and control costs. For example, fertility medication delivery innovations that decrease patient discomfort and time investments can compel payers to update their formulas. Overall, education and dialogue are central to adapting compensation to advancing practices for optimal efficiency and success. Payers should share information with providers on promising developments to collaboratively determine appropriate payment models centered on patient process streamlining and improved results.

Video synopsis is AIgenerated and reviewed by Managed Healthcare Executive® editorial staff.

Related Videos
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Video 3 - "Harnessing Prescription Drug Therapeutics as Monotherapy and Adjunct Therapy"
Video 8 - "Demographic Differences That Impact Care"
Video 7 - "Gaps in Diabetes Education and Self Efficacy"
© 2024 MJH Life Sciences

All rights reserved.